prolactin
Recombinant proteinexperimental
Prolactin (PRL), also known as lactotropin and mammotropin, is a protein best known for its role in enabling mammals to produce milk. It is influential in over 300 separate processes in various vertebrates, including humans. Prolactin is secreted from the pituitary gland in response to eating, mating, estrogen treatment, ovulation and nursing. It is secreted heavily in pulses in between these events. Prolactin plays an essential role in metabolism, regulation of the immune system and pancreatic development. — Wikipedia
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2002 (NCT00438490)
Timeline
2000s
- Jan 1, 2002
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- ProlactinSupplementation
PRL supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaProlactin ↗
Also known as
- prolactin
- prolactin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00181649 | Phase 2 | Sep 1, 2006 | Harvard University |
| NCT00181623 | Phase 2 | Jan 1, 2005 | Harvard University |
| NCT00181610 | Phase 2 | Sep 1, 2004 | Harvard University |
| NCT00438490 | Phase 2 | Apr 1, 2002 | Harvard University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 4 | 4 | 1 | 2002 |
1 organizations
Page 1 / 1